A new London-based artificial intelligence laboratory has officially emerged from its stealth development phase after successfully securing 50 million dollars, which equates to approximately 37.2 million pounds, in its initial major funding round. The newly launched company, named Inherent, intends to completely restructure and modernise the traditional scientific method. This framework of empirical inquiry has remained largely unchanged for the past 400 years, but the founders argue it must now be fundamentally redesigned to operate effectively within the modern era of advanced computer science and machine learning.

The venture is led by a distinct team of technical specialists and policy experts, namely Tantum Collins, Edward Hughes, and Louis Kirsch. The founders bring a wealth of high-level experience from several of the world's most prominent technology and administrative institutions, having previously worked at Google’s artificial intelligence research unit DeepMind, Microsoft, and the White House. This specific combination of backgrounds suggests that the company intends to address not just the raw technical development of advanced computing, but also the broader regulatory, political, and societal implications of autonomous technology.

The primary technological focus of the laboratory is the development of a proprietary artificial intelligence system named Faraday, a title chosen in deliberate tribute to the pioneering 19th-century British physicist and chemist Michael Faraday. Inherent plans to design this software platform to integrate algorithmic curiosity and autonomous exploration capabilities directly into machine learning models. The Faraday system is engineered to work alongside human researchers, assisting them by accelerating data analysis, identifying hidden patterns in complex datasets, and independently managing self-improving computational tasks during the scientific research process.

This significant initial funding round was led by Index Ventures, a prominent international venture capital firm with a history of backing major technology platforms. In addition to institutional capital, the company has attracted substantial financial investment from several high-profile figures within the British technology sector. Among these individual backers is Matt Clifford, the co-founder of the international talent investor Entrepreneur First and a key artificial intelligence advisor to Downing Street, who has been a prominent voice shaping national computing policy.

According to detailed statements released by Index Ventures regarding their investment, the introduction of AI-native science will radically alter the appearance, speed, and structure of traditional laboratory research. The investors note that the future of scientific discovery may become significantly more complex, messier, and less immediately legible to human observers than the neat hypotheses of the past. However, they expect these automated systems to remain entirely capable of delivering exceptional results that cannot be reached through current human computational methods. To illustrate the scale of this projected technological leap, the investors compared the future laboratory environment to a modern research facility, suggesting it would appear entirely alien to a medieval monk who was accustomed to searching for astronomical data within the text of the Bible.

Inherent has also established a distinct legal and regulatory framework to govern its long-term research goals and protect against algorithmic risks. Rather than registering the business as a standard commercial entity focused purely on quarterly returns, the founders have made the deliberate decision to set up the company as a public benefit corporation. This specific corporate structure legally obliges the executive board to balance its financial interests with the broader social benefits of its technological output. The management team stated that this structure was selected because they wish to carefully consider the secondary and tertiary consequences of autonomous scientific discovery, embedding clear ethical guardrails directly into the corporate governance of the firm from its inception.

‍